Testing effectiveness (Phase 2)Study completedNCT02571556
What this trial is testing
OPEN-LABEL, MULTI-CENTER, PHASE 1b/2a CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EFFICACY OF IONTOPHORETIC DEXAMETHASONE PHOSPHATE OPHTHALMIC SOLUTION IN PATIENTS HAVING UNDERGONE CATARACT SURGERY WITH IMPLANTATION OF A POSTERIOR CHAMBER INTRAOCULAR LENS (IOL)
Who this might be right for
Patients Having Undergone Unilateral Cataract Extraction and Implantation of a Monofocal
Eyegate Pharmaceuticals, Inc. 80